Cellular Immunology
A section of Cells (ISSN 2073-4409).
Section Information
The immune system plays a key role in protecting the host from microbes and chemicals preserving the homeostasis of the body. Also, it is involved in sensing danger signals originating from the host components during disease onset and progression as well as repair of tissues. Thus, the immune system can greatly influence the overall physiological and pathophysiological responses. Cells of the innate and adaptive immunity can interact with cellular and matrix components of several tissues and this interaction is strictly regulated. This section of Cells aims to publish findings that provide novel insights and/or conceptual advances to the knowledge of phenotypic, biochemical and molecular features and functional mechanisms of immune cells. Relevant research topics include, but are not limited to, the following:
- innate immunity
- adaptive immunity
- bridge between innate and adaptive immunity
- cross-talk between immune cells and tissue microenvironment
- immunobiology and immunogenetics
- tumor immunology
- cells in immune-mediated diseases
- immunopharmacology
- infection immunology
- neuroimmunology
- transplantation immunology
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- HIV and Immunotherapy (Deadline: 31 October 2023)
- Immune-Related Adverse Events in Cancer Patients—From Pathophysiology to Treatment and Associations with Outcomes (Deadline: 1 November 2023)
- Natural Killer Cells in Cancer Immunotherapy (Deadline: 25 November 2023)
- Role of Extracellular Vesicles in Inflammatory Diseases (Deadline: 30 November 2023)
- HIV–Host Cell Interaction (Deadline: 30 November 2023)
- Cytokines at the Edge between Alarm and Homeostasis (Deadline: 30 November 2023)
- High Mobility Group Box-1 (HMGB1) in a Neuroimmune Crosstalk (Deadline: 30 November 2023)
- Human Inborn Errors of Immunity (Deadline: 10 December 2023)
- Leukocytes in Inflammation, Resolution of Inflammation, Autoimmune Diseases and Cancer—Series 2 (Deadline: 15 December 2023)
- Immunotherapy: A New Challenge in Treating Cancer (Deadline: 15 December 2023)
- Cancer Immunotherapy Harnessing Innate and Adaptive Immune Effector Cells and PD-1 Immune Checkpoint Inhibitors (Deadline: 15 December 2023)
- Role of Inflammasome Activation in Innate and Adaptive Immunity (Deadline: 15 December 2023)
- Mechanisms of Regulatory T Cell, B Cell, and Myeloid Suppressor Cell Activity (Deadline: 15 December 2023)
- The Role of Antimicrobial Peptides and the Gut Microbiota in Autoimmune Diseases (Deadline: 15 December 2023)
- Advances in Cellular and Molecular Treatment of Autoimmune Diseases (Deadline: 20 December 2023)
- Molecular Mechanisms of Immunity to Infectious Viruses (Deadline: 30 December 2023)
- Immunopharmacology: Current Applications and Future Perspectives (Deadline: 31 December 2023)
- Potential of CAR-Based Cellular Immunotherapy for Non-oncologic Disorders (Deadline: 31 December 2023)
- Innate Immunity in Health and Disease (Deadline: 31 December 2023)
- New Insights into Targeted Therapy for Non-Small-Cell Lung Cancer: From Molecular Biology to Tumor Microenvironment (Deadline: 31 December 2023)
- Oral Cancer: Cellular and Molecular Mechanisms of Bone Invasion (Deadline: 31 December 2023)
- Upregulation of the Renin-Angiotensin System Pathways and SARS-CoV-2 Infection: Molecular and Cellular Insights and Possible Therapeutic Strategies (Deadline: 31 December 2023)
- Innate-Acquired Linkage in Immunotherapy—Series II (Deadline: 10 January 2024)
- Advances in the Study of Natural Killer (NK) Cells (Deadline: 20 January 2024)
- Onco-Hematology and Immunotherapy (Deadline: 20 January 2024)
- Role of T Cells from Adaptive Immune Responses to Therapies (Deadline: 31 January 2024)
- Natural Killer Cells and Myeloid Cells in Tumor Microenvironment: How to Enhance Their Anti-tumor Activity? (Deadline: 31 January 2024)
- The Role of Inflammation in AMD (Multifactorial Age-Related Macular Degeneration)—Volume II (Deadline: 31 January 2024)
- Targeting the Tumor Vasculature: From Vascular Normalization to Tumor Immunity (Deadline: 31 January 2024)
- Adipocytes in the Pathogenesis of Autoimmune Rheumatic Diseases (Deadline: 31 January 2024)
- Suppressed but Still at Risk: HIV-Related Complications (Deadline: 15 February 2024)
- Dendritic Cells in Health and Disease (Deadline: 15 February 2024)
- Allergic Airway Disease: Immunology, Pathogenesis, Inflammation (Deadline: 25 February 2024)
- ColoNet: Profiling Molecular and Cellular Networks in the Gastrointestinal Tract (Deadline: 25 February 2024)
- The Role of Macrophages and Neutrophils in Chronic Inflammation-Related Disorders (Deadline: 28 February 2024)
- Extracellular Matrix and Immune Cell Interactions (Deadline: 29 February 2024)
- Untangling the Cross-Talk between Immune Responses and Infection (Deadline: 29 February 2024)
- Synaptic Dysfunction in the Progressive Neurodegeneration of Alzheimer’s Disease and Related Dementia (Deadline: 29 February 2024)
- Recent Advances in Immune Cells in Inflammation and Tissue Regeneration (Deadline: 29 February 2024)
- Advancements in Cancer Immunotherapy beyond Checkpoint Blockade (Deadline: 31 March 2024)
- The Pathogenetic Triad of Chronic Airway Diseases—Inflammation, Tissue Destruction, and Airway Remodeling (Deadline: 31 May 2024)
- Innate Cellular Immunity in Xenotransplantation (Deadline: 27 June 2024)
- New Developments in Rheumatoid Arthritis (Deadline: 31 July 2024)
Topical Collections
Following topical collections within this section are currently open for submissions:
- Advances in Immune Monitoring
- Allergy, Asthma and Clinical Immunology
- Cellular Immunology and COVID-19
- Emerging Roles of Neutrophil in Inflammation and Immunity
- Feature Papers in ‘Cellular Immunology’
- Gut Microbiota-Derived Metabolites and Host Gut-Brain Communication
- Immuno-Metabolic Crosstalk in Oncogenesis
- Mast Cells in Health and Diseases
- The Increasingly Fascinating World of Interleukins
- The New Era of Mesenchymal Stromal/Stem Cell Functional Application: State of the Art, Therapeutic Challenges and Future Directions
- Trends and Advances in Tumor Immunology
